Recombinant Anti-p73 (phospho Y99) antibody [EPR21751] (ab218625)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR21751] to p73 (phospho Y99)
- Suitable for: Dot blot, WB, IP
- Reacts with: Human
Related conjugates and formulations
Overview
-
Product name
Anti-p73 (phospho Y99) antibody [EPR21751]
See all p73 primary antibodies -
Description
Rabbit monoclonal [EPR21751] to p73 (phospho Y99) -
Host species
Rabbit -
Tested applications
Suitable for: Dot blot, WB, IPmore details -
Species reactivity
Reacts with: Human -
Immunogen
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: HT-1376 treated with 1 mM pervanadate for 30 minutes, whole cell lysate. IP: HT-1376 treated with 1 mM pervanadate for 30 minutes, whole cell lysate.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR21751 -
Isotype
IgG -
Research areas
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab218625 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Dot blot |
1/1000.
|
|
WB |
1/1000. Detects a band of approximately 80 kDa (predicted molecular weight: 69 kDa).
|
|
IP |
1/30.
|
Notes |
---|
Dot blot
1/1000. |
WB
1/1000. Detects a band of approximately 80 kDa (predicted molecular weight: 69 kDa). |
IP
1/30. |
Target
-
Function
Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. -
Tissue specificity
Expressed in striatal neurons of patients with Huntington disease (at protein level). Brain, kidney, placenta, colon, heart, liver, spleen, skeletal muscle, prostate, thymus and pancreas. Highly expressed in fetal tissue. -
Sequence similarities
Belongs to the p53 family.
Contains 1 SAM (sterile alpha motif) domain. -
Domain
Possesses an acidic transactivation domain, a central DNA binding domain and a C-terminal oligomerization domain that binds to the ABL tyrosine kinase SH3 domain.
The WW-binding motif mediates interaction with WWOX. -
Post-translational
modificationsIsoform alpha (but not isoform beta) is sumoylated on Lys-627, which potentiates proteasomal degradation but does not affect transcriptional activity.
Higher levels of phosphorylation seen in the brain from patients with Huntington disease.
Ubiquitinated; leading to its degradation by the proteasome. -
Cellular localization
Nucleus. Accumulates in the nucleus in response to DNA damage. - Information by UniProt
-
Database links
- Entrez Gene: 7161 Human
- Omim: 601990 Human
- SwissProt: O15350 Human
- Unigene: 697294 Human
- Unigene: 706990 Human
-
Alternative names
- p53 like transcription factor antibody
- p53 related protein antibody
- p53-like transcription factor antibody
see all
Images
-
All lanes : Anti-p73 (phospho Y99) antibody [EPR21751] (ab218625) at 1/1000 dilution
Lane 1 : Untreated HT-1376 (human urinary bladder carcinoma cell line) whole cell lysate
Lane 2 : HT-1376 treated with 1 mM pervanadate for 30 minutes, whole cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 69 kDa
Observed band size: 80 kDa why is the actual band size different from the predicted?
Exposure time: 15 secondsBlocking/Dilution buffer: 5% NFDM/TBST.
The molecular mass observed is consistent with the literature (PMID:11466610).
-
p73 (phospho Y99) was immunoprecipitated from 0.35 mg of HT-1376 (human urinary bladder carcinoma cell line) treated with 1mM Pervanadate for 30 min whole cell lysate with ab218625 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218625 at 1/2000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/10000 dilution.
Lane 1: HT-1376 treated with 1mM Pervanadate for 30 min whole cell lysate 10 μg (input).
Lane 2: ab218625 IP in HT-1376 treated with 1mM Pervanadate for 30 min whole cell lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab218625 in HT-1376 treated with 1mM Pervanadate for 30 min whole cell lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 seconds.
-
Dot blot analysis of p73 (phospho Y99) with ab218625 at 1/1000 dilution.
Lane 1: p73 (phospho Y99) peptide.
Lane 2: p73 non-phospho peptide.
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Blocking/Dilution buffer: 5% NFDM/TBST.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
Certificate of Compliance
References (0)
ab218625 has not yet been referenced specifically in any publications.